text
"[""\nX. 대주주 등과의 거래내용\n가. 대주주 등에 대한 신용공여 등해당사항 없습니다.나. 대주주와의 자산양수도 및 영업거래 등보고서 작성기준일 현재 회사의 대주주 및 특수관계자 등에 대한 재화의 판매 또는 용역의 제공과 구입내역은 다음과 같습니다. 자세한 내역은 'III. 재무에 관한 사항 - 3. 연결재무제표 주석 - 23. 특수관계자 거래'를 참고하시기 바랍니다.\n[당반기]\n(단위: 천원)\n구 \xa0분\n회사명\n수익 등\n비용 등\n제품/상품매출\n용역/서비스제공\n임대수익\n기타\n재고자산매입 등\n용역/서비스비용\n연구비용\n기타\n최상위지배기업\n(주)대웅\n196,743\n98,650\n343,972\n-\n385,150\n18,213,045\n9,405,383\n2,047\n관계기업\n(주)엠디웰아이앤씨\n6,996\n930\n9,763\n-\n1,187\n50,257\n91\n62,549\n(주)바이오시네틱스\n-\n-\n-\n-\n-\n370\n1,480\n-\n(주)다나아데이터\n-\n-\n4,800\n-\n-\n-\n-\n-\nImmplacate, Inc.\n-\n-\n-\n9,632\n-\n-\n-\n-\n기타특수관계자\n대웅바이오㈜\n9,310,888\n96,800\n-\n-\n28,626,204\n14,364,804\n3,010\n-\n(주)아이디에스앤트러스트\n11,026\n19,140\n49,632\n5,885\n53,708\n258,288\n260,898\n-\n(주)대웅경영개발원\n300\n-\n83,207\n-\n3,373\n40,844\n141,416\n189,327\n(주)대웅생명과학\n-\n-\n-\n-\n273\n-\n-\n235,680\n(주)대웅이엔지\n2,130\n10,005\n1,523\n1,661\n5,192,392\n450,256\n121,276\n216,754\n(주)산웅개발\n132\n-\n-\n-\n22,487\n143,524\n-\n54,025\n(주)대웅개발\n-\n671\n379,688\n-\n56,540\n318,638\n-\n587,030\n(주)팜팩\n4,361\n-\n170\n-\n1,226,334\n-\n-\n-\n(주)에스티에이치이솔루션\n-\n2,923\n-\n-\n-\n15,501\n-\n3,318\n(주)대웅펫\n27,082\n1,725\n21,227\n-\n2,454\n126\n303,709\n30,728\n(주)대웅테라퓨틱스\n3,750\n-\n-\n-\n-\n-\n1,200,000\n-\n(주)디더블유메디팜\n-\n-\n-\n830\n268,314\n-\n79,900\n8,949\n(주)대웅인베스트먼트\n-\n-\n2,491\n10,715\n-\n-\n-\n-\n(주)알피스페이스\n-\n4,093\n-\n-\n158,299\n1,403\n50\n827,045\n(주)알피바이오\n-\n-\n-\n-\n2,864,568\n-\n-\n-\n(주)이지메디컴\n1,128,940\n6,590\n-\n-\n-\n464,841\n5,844\n2,641,486\n(주)시지바이오\n1,136,009\n58,812\n75,600\n-\n4,140,345\n137,484\n-\n25,924\n(주)바이오에이지\n307\n870\n-\n-\n9,000\n-\n9,600\n288,385\n(주)디엔홀딩스\n1,056\n2,958\n15,512\n7,300\n-\n-\n-\n-\n(주)디엔코스메틱스\n647,375\n7,382\n15,512\n4,831\n900,471\n-\n3,003\n988,714\n(주)디엔컴퍼니\n9,677,751\n7,134\n38,595\n-\n-\n370,809\n-\n-\n(주)엠서클\n28,204\n33,144\n58,505\n-\n114,353\n6,896,729\n5,464\n3,628,004\n기타\n995,425\n56,208\n45,612\n-\n535\n75,428\n3,960\n119,435\n합 \xa0계\n23,178,475\n408,035\n1,145,809\n40,854\n44,025,987\n41,802,347\n11,545,084\n9,909,400\n[전반기]\n(단위: 천원)\n구 \xa0분\n회사명\n수익 등\n비용 등\n제품/상품매출\n용역/서비스제공\n임대수익\n기타\n재고자산매입 등\n유무형자산매입\n용역/서비스비용\n연구비용\n기타\n최상위지배기업\n(주)대웅\n18,855\n153,486\n294,935\n22,709\n606,715\n-\n17,577,426\n8,098,178\n254\n관계기업\n(주)엠디웰아이앤씨\n4,435\n5,194\n6,444\n-\n-\n-\n57,502\n-\n59,188\n기타특수관계자\n대웅바이오(주)\n6,956,653\n125,941\n-\n3,426\n21,556,717\n7,848,000\n11,028,177\n173,317\n-\n(주)아이디에스앤트러스트\n364\n34,364\n32,757\n16,308\n64,450\n-\n405,705\n2,415\n-\n(주)대웅경영개발원\n-\n-\n236,499\n-\n-\n-\n100,580\n235,967\n117,735\n(주)대웅생명과학\n-\n-\n-\n-\n390\n-\n-\n-\n280,130\n(주)시지바이오\n2,051,220\n112,991\n75,600\n141,748\n4,670,743\n-\n353,597\n-\n21,976\n(주)디엔코스메틱스\n174,822\n13,974\n20,476\n80,930\n426,367\n-\n532\n1,818\n1,114,621\n(주)디엔컴퍼니\n12,446,113\n19,199\n47,778\n-\n-\n-\n434,459\n-\n-\n(주)대웅이엔지\n495\n21,564\n1,183\n-\n1,721,726\n-\n70,869\n-\n-\n(주)산웅개발\n-\n4,909\n12,623\n-\n67,110\n-\n390,614\n-\n83,145\n(주)알피바이오\n-\n-\n-\n-\n3,197,247\n-\n-\n-\n14,209\n(주)이지메디컴\n915,997\n14,250\n-\n3,257\n-\n-\n500,623\n2,634\n2,468,885\n(주)대웅개발\n-\n-\n337,169\n-\n-\n-\n-\n-\n227,083\n(주)팜팩\n2,277\n27,545\n510\n-\n2,880,222\n-\n-\n-\n-\n(주)엠서클\n9,660\n58,166\n38,759\n3,229\n47,702\n-\n7,269,056\n2,904\n2,979,285\n기타\n920,151\n23,070\n59,382\n12,459\n1,308,676\n-\n301,214\n13,082\n1,416,936\n합 \xa0계\n23,501,042\n614,653\n1,164,115\n284,066\n36,548,065\n7,848,000\n38,490,354\n8,530,315\n8,783,447\n""]"
